FDA seeks comments on medical-imaging guidance

10/13/2008 | HealthImaging.com

The FDA is accepting public comments on a draft guidance for makers of medical-imaging drugs and devices that provide contrast enhancement. The guidance focuses on developing contrast indications for imaging devices that use approved drugs or biological products. It also contains recommendations to promote the timely and effective evaluation and regulation of imaging drugs and devices.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ